Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

132 ARTÍCULOS , VIENDO DEL 16 AL 30

Relationship of Suboptimal and Disordered Sleep with Cardiovascular Disease and Its Risk Factors - A Narrative Review

Wipper B, Mayer-Suess L, Cesari M, Ibrahim A, Winkelman J, Kiechl S.

Neuroepidemiology. 2025;59(2):176-192. doi: 10.1159/000539369. Epub 2024 Jun 8.

Research on sleep disorders in patients with mental illness: A review of Indian studies

Pal A, Saini LK, Basu A, Kachhawaha G, Kundu K, Gupta R.

Indian J Psychiatry. 2025 May;67(5):469-481. doi: 10.4103/indianjpsychiatry.indianjpsychiatry_110_25. Epub 2025 May 15.

Pediatric sleep movements: a review of methodologies, normative data, disease associations, and research gaps

Lu M, Fitzgerald DA, Norman MB, Sullivan CE, Waters KA.

J Clin Sleep Med. 2025 Oct 1;21(10):1773-1785. doi: 10.5664/jcsm.11748.

Case Report: Near-fatal adverse effects of dopamine agonist for the treatment of restless legs syndrome

Joyce JB, Patarroyo Rodriquez L, Sola CL.

Front Pharmacol. 2025 Oct 31;16:1697935. doi: 10.3389/fphar.2025.1697935. eCollection 2025.

Synaptic and Non-Synaptic Functions of PTPRD: A Receptor Tyrosine Phosphatase at the Crossroads of Neural Circuitry and Metabolism

Kim S, Shin JJ, Kang M, Yi Y, Kim E.

J Neurochem. 2025 Nov;169(11):e70292. doi: 10.1111/jnc.70292.

Validation of the eHealth Literacy Scale Instrument in a Restless Legs Syndrome Population: Classical Test Theory and Rasch Analysis Study

Georgsson M, Odzakovic E, Björk M, Kaldo V, Jernelöv S, Blom K, Ulander M, Fridlund B, Knutsson S, Sandlund C, Pakpour A, Broström A.

J Med Internet Res. 2025 Sep 10;27:e68474. doi: 10.2196/68474.

Aripiprazole Has Potential Efficacy for Antidepressant-induced Restless Legs Syndrome: A Case Series

Nagai Y, Miyakawa K.

Clin Psychopharmacol Neurosci. 2025 Nov 30;23(4):728-732. doi: 10.9758/cpn.25.1316. Epub 2025 Jul 28.

A comparative study of depressive and anxiety symptoms, insomnia, and sleepiness in patients with obstructive sleep apnea, restless legs syndrome, or both (CO-ROSA): preliminary findings from a retrospective study

DelRosso LM, Bradshaw S, Singh A, Jain V, Mogavero MP, Ferri R.

Int Clin Psychopharmacol. 2025 Sep 1;40(5):275-280. doi: 10.1097/YIC.0000000000000571. Epub 2024 Dec 23.

Suggested immobilization test in RLS clinical trials: A systematic review and methodological appraisal

Gorantla S, Gorijala VK, Trotti LM.

Sleep Med. 2025 Dec;136:106828. doi: 10.1016/j.sleep.2025.106828. Epub 2025 Sep 23.

Commentary: Understanding restless legs syndrome and its impact on sleep and daily life

Berdida DJE.

J Res Nurs. 2025 Dec 5;31(1-2):17449871251385997. doi: 10.1177/17449871251385997. Online ahead of print.

Sleep and circadian difficulties in schizophrenia: presentations, understanding, and treatment

Freeman D, Waite F.

Psychol Med. 2025 Feb 17;55:e47. doi: 10.1017/S0033291725000297.

Research progress in sleep disorders associated with multiple sclerosis

Zhang S, Wang R, Zhang G, Zhao X.

Mult Scler Relat Disord. 2025 Nov;103:106639. doi: 10.1016/j.msard.2025.106639. Epub 2025 Jul 26.

Prevalence and impact of sleep disorders in osteoarthritis: A systematic review and meta-analysis

Mathieu S, Rat AC, Sellam J.

Osteoarthr Cartil Open. 2025 Dec 24;8(1):100738. doi: 10.1016/j.ocarto.2025.100738. eCollection 2026 Mar.

Restless legs syndrome associated with teriflunomide use in two patients with multiple sclerosis

Aksoy D, Çevik B.

Clin Neurol Neurosurg. 2025 Jan;248:108665. doi: 10.1016/j.clineuro.2024.108665. Epub 2024 Nov 26.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias